LOG IN

Members and suppliers: Join our online community

Access our full library of resources, register for events and webinars and share audits and other assessments

News

Sort By
This event was published on 19 June
Registration Open
2024 PSCI India Conference

2024 PSCI India Conference

Conference | 24–26 Sep 2024

Join us on 24-26 September in Goa to learn from industry expert insights on important pharma-related topics, explore best practice and upcoming trends related to the PSCI Principles, and network with your peers.

Please note the registration will open in 2 stages, as follows:

  • Stage 1: 3 June - 28 June, open only to participants who would like to stay at Radisson Blu Resort during the conference
    • We have negotiated a very special rate of INR 9500/- + taxes per day (including all meals) at the Radisson Blu Resort Goa Cavelossim Beach, South Goa for 80 rooms.
    • These rooms are available on a first-come-first-served basis. The rate remains the same for single occupancy and twin-sharing basis.
    • If you wish to book your stay at this special rate, please complete the hotel booking (available here), pay for your stay, and click on 'Submit'. Once done, please come back to this page and click on 'Register now'. You will be asked to provide the payment ID number before your registration is confirmed. Please note that you won't be able to register for the conference at this stage if you haven't paid for your room.

This first stage will be open until 28 June or until all rooms are booked, whichever is earlier.

  • Stage 2: 1 July - 15 September, open to all participants
    • If any rooms are left, participants will be able to book hotel rooms at the preferable rate.

Please note that the conference will also feature an exhibition of pharmaceutical suppliers' good practices and success stories relevant to the PSCI Principles. If you are interested in showcasing your organization's work, please get in touch with us by emailing subhash.babu@issehs.com.

Finally, participants are invited to submit ahead of time any questions regarding the topics that will be covered during the conference which they'd like to see answered by the relevant speaker(s). Please click on this link to do so, and keep the questions as brief and focused as possible.

In case of any queries or doubts, please do get in touch with:

  1. Subhash Babu (+91 9327547484) for first point of contact
  2. Aditya Shirodkar (+91 7030129399) secondary contact
  3. Amish Kamat (+91 9823113249) tertiary contact

We request that each organization appoints a maximum of 2 (in exceptional cases 3) participants.

The conference agenda will be added in due course.

Type
Conference
Date
24–26 Sep 2024
Language
English
Add To Calendar

If you have a PSCI account, please log in first so your information will be filled automatically.

All fields are required except where specified. Please enter all information in English.

Full Members

  • Abbott
  • AbbVie
  • Acino International AG
  • AstraZeneca
  • Aurobindo
  • BASF Pharma
  • Baxter
  • Bayer
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Catalent Inc
  • Centrient Pharmaceuticals
  • Coloplast
  • Elanco Animal Health
  • Grunenthal GmbH
  • GSK
  • Haleon
  • Johnson & Johnson
  • Kenvue
  • Lilly
  • Mallinckrodt
  • Merck & Co.
  • Novartis
  • Novo Nordisk
  • Orion
  • Pfizer
  • Piramal
  • Roche
  • Sandoz
  • Sanofi
  • Sartorius
  • STA Pharmaceuticals
  • Takeda
  • Teva
  • UCB
  • Viatris
  • West Pharmaceutical Services Inc.
  • Zoetis

Associate Members

  • Alkem Laboratories
  • Almirall
  • Amgen
  • Aragen Life Sciences Limited
  • Ascendis
  • Aspen Pharmacare
  • Bavarian Nordic
  • Beckton Dickinson
  • Biogen
  • Charles River Laboratories
  • Chiesi
  • Chugai Pharmaceutical
  • Cipla
  • CSL Limited
  • Eisai Co., Limited
  • Esteve
  • Evolan Pharma AB
  • Fabbrica Italiana Sintetici S.p.a.
  • Gilead
  • Immedica Pharma
  • IOI Oleo
  • Karo Healthcare
  • LEO Pharma
  • Lonza
  • Mallax Pharmaceutical
  • Merck KGaA
  • Moderna
  • Nordic Pharma B.V.
  • Ono Pharmaceuticals
  • Organon
  • Orifarm
  • Perrigo Company
  • Reckitt
  • Sai Life Sciences
  • Shionogi
  • SK Biopharmaceuticals
  • Sobi
  • Sterling Pharma Solutions
  • ten23 health
  • Tiefenbacher Group
  • Vertex
  • Vetoquinol
  • Xellia Pharmaceuticals

Please confirm your booking at the venue:

Radisson Blu Resort Goa, Cavelossim Beach, Mobor, Goa 403001

We will not pass on these details to third parties and will use them only to contact you about this event, or other PSCI events we think you may be interested in.

Please contact us if you find you can no longer attend.

I understand that these details will be used by the PSCI to identify me and to send me communications relating to this, and future, PSCI events.

Leave this field blank if you are a human.
Registration Closes: 15 Sep 2024
If you have a user account, please log in before registering.
This bulletin was published on 29 May
CDMO Live: Accelerate, De-Carbonise and Optimise contract manufacturing

CDMO Live: Accelerate, De-Carbonise and Optimise contract manufacturing

The PSCI at CDMO Live
PSCI Vice Chair, Rob Williams, will be speaking at CDMO Live on Strategies for Reducing Scope 3 Emissions with Manufacturing Partners. You can find out more here.

In the dynamic world of BioPharma, Contract Development and Manufacturing Organisations (CDMO) have become the catalyst that accelerates and enables innovation.

At a time when high-profile acquisitions and partnerships re-shaping the landscape of development and manufacturing, CDMO Live is an exclusive online event designed to put the spotlight on contract manufacturers and the pivotal role of outsourcing.

Taking place 13th June 2024, the event will help attendees to discover the latest trends in contract manufacturing and connect with potential partners. Through expert talks and workshops attendees will learn valuable insights into how to:

  1. Accelerate drug development and manufacturing with innovative partners
  2. De-Carbonise by reducing Scope 3 emissions and achieve your environmental goals
  3. Optimise your contract manufacturing network for operational efficiencies, resilience and quality

Creating Partnerships
At the core of the event is PartnerMatch, a carefully curated 1-to-1 meeting programme to connect outsourcing leaders with solutions to address their specific needs and challenges. Driven by AI-powered meeting platform and the PharmaSource concierge team, it is a highly efficient way to meet relevant potential partners.

Register to attend
CDMO Live is free to attend. Join us on 13th June 2024 by registering here.

About CDMO Live
CDMO Live is a new event from PharmaSource and Life Science Networks. Find out more by heading to PharmaSource.global.

This resource was published on 16 May
The PSCI publishes progress towards sustainable supply chains in its 2023 Annual Report

The PSCI publishes progress towards sustainable supply chains in its 2023 Annual Report

Report

The Pharmaceutical Supply Chain Initiative (PSCI) has released its 2023 Annual Report, celebrating its 10th anniversary and showcasing the efforts of the pharmaceutical and healthcare industry to build responsible supply chains. The report showcases the sector’s progress through its three modes of impact: Audit, Capability, and Projects.

More Info…
This resource was published on 3 May

Request to Tender: The Link 2.0

Document

During 2024 we will be updating/replacing The Link – the online platform by which we communicate with members and share audits.

We have today launched an open tender exercise to find the best provider. The attached documents have been sent to a small group of selected bidders.

We would welcome the widest possible range of submissions.

Supporting documents:

PSCI Link 2.0 RFP - via the download button below.
Link system map
Link 2.0 user requirements

For ease, please note the following:

Address for correspondence is: LinkRFP@pscinitiative.org
Please confirm your interest to participate by: 10th May 2024
Bid submission deadline: 31st May 2024

This event was published on 29 April
Webinar: Handling of Potent Compounds in the Manufacturing of APIs and Medicines

Webinar: Handling of Potent Compounds in the Manufacturing of APIs and Medicines

Webinar | 28 May 2024 15:00–16:00 Beijing

本线上研讨会由PSCI中国小组筹备,目标观众为中国供应商;会议语言为英语,欢迎国际观众注册参与。会议使用PPT为中英双语。
The webinar is sponsored by PSCI China regional team and targeting at suppliers in China.
The presentation will be delivered in English, and international audience is welcome to register & join. The presentation slides would be bilingual in Mandarin/ English.

研讨会话题
原料药和制剂生产中的活性物质操作

注册/登录PSCI账户后即可报名,报名将于5月21日下午17:00点截止。参会指引邮件将于5月22日发出。

线上研讨会话题简介
活性物质(API)的操作在药品生产过程中是一项具有挑战性的任务,一方面要避免操作人员过度职业暴露于活性物质,另一方面要避免药物交叉污染给用药患者带来不良的治疗影响。本次研讨会中,两位全球专家将基于现有GMP法规,阐述PDE和OEL值的理论设定; 从工业卫生(IH)和质量管理(GMP)领域的理论背景出发,深入探讨风险管理、遏制(containment)策略,以及相关的技术解决方案,并分享一些工程控制实例。

分享嘉宾
来自德国勃林格殷格翰总部的EHS 法规智能负责人Reinhold Maeck博士将介绍相关的原理和法规背景,来自瑞士罗氏制药全球工程咨询业务负责人Rainer Nicolai 博士将带来技术领域的深入分享。

会议语言
本次研讨会会议语言为英语。

Topic
Handling of Potent Compounds in the Manufacturing of APIs and Medicines

Please register your attendance before 21st May. We'll send out meeting instructions & link on 22nd May.

Introduction
The handling of potent compounds in the manufacturing of medicines is a challenging task. On the one hand there are operators to be protected from overexposure to materials handled, and on the other hand there are patients to be protected against false treatment due to cross contamination of medicines. In this seminar, not only both aspects will be addressed but also explained why the existing GMP regulations do help to ensure the OEL and PED values are available. Starting with the theoretical background and explaining what the expectations in the field of industrial hygiene (IH) and Good Manufacturing Practice (GMP) are, the seminar will dive into aspects of risk handling, containment strategies and technical solutions giving many examples of engineering controls to protect both - operators and patients - by technical means.

The first part on the theoretical background and the legislative situation will be covered by Dr. Reinhold Maeck, leading global EHS Regulatory Intelligence at Boehringer-Ingelheim.

The second part, diving into the technical aspects will be covered by Dr. Rainer Nicolai, Product Owner Engineering Consulting at Roche, Switzerland.

Your Presenters

  • Reinhold Maeck, PhD
    Boehringer Ingelheim GmbH
    EHS Regulatory Intelligence
    Corp. EHS Regulatory Intelligence and Corporate Lead Auditor
    Chemical/ Chemical Engineering Background
    More than 30 years of International Experience in Pharmaceutical Industry
  • Rainer Nicolai, PhD
    F. Hoffman - La Roche Ltd
    Product Owner Engineering Consulting
    Subject Matter Expert in Containment Technology
    Engineering Background
    More than 25 years of Experience in Contained Handling of Substances
Type
Webinar
Date
28 May 2024 15:00–16:00 Beijing
Language
English
This event is in the past
This bulletin was published on 24 April
PSCI Supply Chain Materiality in 2024: Assessment Report

PSCI Supply Chain Materiality in 2024: Assessment Report

PSCI has conducted a materiality review for the sector every few years (2013, 2017, 2020). We are pleased to publish our latest assessment, this time applying a double materiality framework. The assessment is specifically focused on supply chains for the Pharmaceutical & Healthcare industries, and takes into account member views and a range of outside sources.

“New regulations and investor demands are raising the bar for company reporting on supply chain responsibility. This year's assessment highlights the growing importance of robust supply chain programs, encompassing a wider range of issues. It also reflects the changing nature of the industry’s products and markets, with biosafety joining the list for the first time and the issue of substandard and falsified medicines gaining prominence. Tackling climate change remains essential, as does responsible business practice against bribery and corruption. The PSCI Board uses this assessment as a control point to guide its own strategy. It can be a valuable resource for member companies comparing their own assessments and for those outside the sector to understand how supply chain risks are viewed within the industry. I hope you find it useful.” Dr. Deirdre O’Reilly Global EH&S Supplier Operations and Business Development Lead, Viatris & PSCI Chair

We encourage members, suppliers and our other stakeholders and invited to read the report and use it as an input to their own planning processes.

For anyone with comments to the report, please contact Rosie.Towe@Carnstone.com.

This event was published on 24 April
Registration Open

2024 PSCI China Supplier Conference 中国供应商大会 (南京)

Conference | 10–11 Sep 2024

The 2024 PSCI China Supplier Conference will continue to focus on supplier capability building in the areas of Health and safety, Environment, Human rights, Governance and Management Systems, and Ethics.
2024年 PSCI 年度供应商专业发展大会将继续围绕PSCI原则,关注供应商在健康与安全环境人权治理与管理体系商业道德方面的能力建设。我们邀请PSCI成员、供应商及行业专家为供应商解读上述领域的最佳实践,并探讨行业面临的挑战,也使供应商有机会了解同行、合作伙伴在相关领域的优秀实践,进一步发展专业知识。

  • 会议语言 Language: 中文 Mandarin
  • 会议日期 Date: 9月10日 ,9月 11日 10th - 11th September
  • 会议时间 Time: 9:30-18:00 北京时间 9:30-18:00 Beijing time
  • 地点 Location: 南京玄武湖假日酒店 Nanjing Xuanwu Lake Holiday Inn

目前多个议题的演讲嘉宾/讲师正在招募中,如您愿意作为讲师/参与互动分享,请联系PSCI秘书处 Simeng Wu (simeng.wu@carnstone.com); Danran Chen (danran.chen@carnstone.com). 嘉宾/讲师需求详见以下议程。

  • 报名指南 How to register: 点击下方REGISTER NOW > 用英文填写报名信息(PSCI注册用户请先行登录,系统将自动填写您的信息)> 勾选报名场次 > 点击右下角 ‘Register' 提交报名。为准确统计每天的参会人数,如您仅参加第一天/第二天的会议,请按需准确选择。

报名成功后,您的报名邮箱将收到系统自动发出的确认邮件。参会指引信息将于8月初发送至您的报名登记邮箱。您可点击如下 “Add to Calendar” 添加至日历提醒。若有任何注册相关问题,请联系秘书处 danran.chen@carnstone.com; simeng.wu@carnstone.com

9月10日: 管理体系 Mgmt System | 劳工与商业道德 Human Rights & Ethics | 环境 Env
10 Sep 2024 09:30–18:00 Beijing

建议参会人员:公司管理层、人力资源、环境战略部门
Recommended for: Senior management, HR, Environment departments

会议第一天,我们将邀请PSCI成员公司及供应商嘉宾进行主题演讲,旨在提高供应商在劳工权益、环境等方面的管理水平。

演讲内容将包含:PSCI审计问卷中治理&管理体系的部分内容更新、审计准备及常见审计发现项等;供应链企业的减碳措施;环境中的抗生素。更多内容正在筹备中。部分话题正在招募讲师,如您有意主讲,请联系秘书处Danran (danran.chen@carnstone.com)

暂定议程 Tentative agenda:

  • Registration 观众注册
  • Open Remarks 特邀嘉宾开场致辞
  • Changes to the Governance & Management Systems section of the SAQ PSCI审计SAQ模板中治理&管理体系部分更新 (讲师招募中)
  • Impact on businesses sustainability of the development of the Chinese labor market 中国劳动力市场发展对商业可持续的影响 (暂定议程)
  • Common PSCI human rights / labor audit findings & corrective actions PSCI审计常见劳工发现项&整改计划
  • PiE/ AMR Presentation (Topic TBD) 环境中的抗生素主旨演讲 (话题待确定)
  • Decarbonization Presentation (Topic TBD) 减碳主旨演讲 (话题待确定)

9月11日:安全 Safety | 工业卫生 Industrial Hygiene | 环境 Env
11 Sep 2024 09:30–18:00 Beijing

建议参会人员:EHS 管理人员、供应链经理等
Recommended for: EHS professionals, Supply chain managers

会议第二天,我们将邀请PSCI成员公司及供应商嘉宾进行主题演讲,旨在针对EHS领域(安全、工业卫生、环境)的重点议题及实践难点进行讲解和最佳实践分享,提高供应商EHS实践水平。

演讲内容将包含:工业卫生管理中的量化分析方法、安全文化建设及最佳管理实践、重要安全设施维护等。

部分话题讲师招募中,如您有意主讲,请联系秘书处Danran (danran.chen@carnstone.com)

暂定议程 Tentative agenda:

  • Registration 观众注册
  • Keynote Speech 特邀嘉宾主旨演讲
  • Environment Presentation I (Topic TBD) 环境主旨演讲I(话题待确定)
  • Environment Presentation II (Topic TBD) 环境主旨演讲II(话题待确定)
  • Exposure Assessment and Containment Capabilities with Statistics and Bayesian Analysis 使用统计数据和贝叶斯分析进行暴露分析
  • Case study: the building of safety culture 安全文化建设
  • Safety - best practices on significant Injury and fatality (SIF) prevention programmes SIF预防项目中的最佳实践 (讲师招募中)
  • Best practices of process safety management 工艺流程安全供应商最佳实践 (讲师招募中)
  • Mechanical integrity: Safety critical equipment that are of concern 机械完整性:重要安全设施及维护
Add To Calendar

If you have a PSCI account, please log in first so your information will be filled automatically.

All fields are required except where specified. Please enter all information in English.

Full Members

  • Abbott
  • AbbVie
  • Acino International AG
  • AstraZeneca
  • Aurobindo
  • BASF Pharma
  • Baxter
  • Bayer
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Catalent Inc
  • Centrient Pharmaceuticals
  • Coloplast
  • Elanco Animal Health
  • Grunenthal GmbH
  • GSK
  • Haleon
  • Johnson & Johnson
  • Kenvue
  • Lilly
  • Mallinckrodt
  • Merck & Co.
  • Novartis
  • Novo Nordisk
  • Orion
  • Pfizer
  • Piramal
  • Roche
  • Sandoz
  • Sanofi
  • Sartorius
  • STA Pharmaceuticals
  • Takeda
  • Teva
  • UCB
  • Viatris
  • West Pharmaceutical Services Inc.
  • Zoetis

Associate Members

  • Alkem Laboratories
  • Almirall
  • Amgen
  • Aragen Life Sciences Limited
  • Ascendis
  • Aspen Pharmacare
  • Bavarian Nordic
  • Beckton Dickinson
  • Biogen
  • Charles River Laboratories
  • Chiesi
  • Chugai Pharmaceutical
  • Cipla
  • CSL Limited
  • Eisai Co., Limited
  • Esteve
  • Evolan Pharma AB
  • Fabbrica Italiana Sintetici S.p.a.
  • Gilead
  • Immedica Pharma
  • IOI Oleo
  • Karo Healthcare
  • LEO Pharma
  • Lonza
  • Mallax Pharmaceutical
  • Merck KGaA
  • Moderna
  • Nordic Pharma B.V.
  • Ono Pharmaceuticals
  • Organon
  • Orifarm
  • Perrigo Company
  • Reckitt
  • Sai Life Sciences
  • Shionogi
  • SK Biopharmaceuticals
  • Sobi
  • Sterling Pharma Solutions
  • ten23 health
  • Tiefenbacher Group
  • Vertex
  • Vetoquinol
  • Xellia Pharmaceuticals

Please indicate which sessions you plan to attend:

10 Sep 2024

11 Sep 2024

We will not pass on these details to third parties and will use them only to contact you about this event, or other PSCI events we think you may be interested in.

Please contact us if you find you can no longer attend.

I understand that these details will be used by the PSCI to identify me and to send me communications relating to this, and future, PSCI events.

Leave this field blank if you are a human.
Registration Closes: 23 Aug 2024
If you have a user account, please log in before registering.
  • Ethics
  • Human Rights & Labor
  • Health & Safety
  • Process Safety
  • Environment
  • Management Systems
  • Data Security
  • Waste Management
  • Pharmaceuticals In The Environment
  • Anti-Microbial Resistance
  • Audit Program
This event was published on 16 April
CDMO Live: Accelerate, De-Carbonise and Optimise contract manufacturing

CDMO Live: Accelerate, De-Carbonise and Optimise contract manufacturing

External | 13 Jun 2024 09:00–17:00 London

CDMO Live: Accelerate, De-Carbonise and Optimise contract manufacturing

In the dynamic world of BioPharma, Contract Development and Manufacturing Organisations (CDMO) have become the catalyst that accelerates and enables innovation.

At a time when high-profile acquisitions and partnerships re-shaping the landscape of development and manufacturing, CDMO Live is an exclusive online event designed to put the spotlight on contract manufacturers and the pivotal role of outsourcing.

Taking place 13th June 2024, the event will help attendees to discover the latest trends in contract manufacturing and connect with potential partners. Through expert talks and workshops attendees will learn valuable insights into how to:

  1. Accelerate drug development and manufacturing with innovative partners
  2. De-Carbonise by reducing Scope 3 emissions and achieve your environmental goals
  3. Optimise your contract manufacturing network for operational efficiencies, resilience and quality

Creating Partnerships
At the core of the event is PartnerMatch, a carefully curated 1-to-1 meeting programme to connect outsourcing leaders with solutions to address their specific needs and challenges. Driven by AI-powered meeting platform and the PharmaSource concierge team, it is a highly efficient way to meet relevant potential partners.

Register to attend
CDMO Live is free to attend. Join us on 13th June 2024 by registering here.

The PSCI at CDMO Live
PSCI Vice Chair, Rob Williams, will be speaking at CDMO Live on Strategies for Reducing Scope 3 Emissions with Manufacturing Partners. You can find out more here.

About CDMO Live
CDMO Live is a new event from PharmaSource and Life Science Networks. Find out more by heading to PharmaSource.global.

Type
External
Date
13 Jun 2024 09:00–17:00 London
Venue
Language
English
This event is in the past
This event was published on 10 April
PSCI Webinar: SafeBridge Session on OELs and transition from an OEB/OHC to an OEL

PSCI Webinar: SafeBridge Session on OELs and transition from an OEB/OHC to an OEL

Webinar | 9 May 2024 15:00–16:00 London

Join us on May 9 15:00 – 16:00 (CET)

This webinar is a follow up from the first SafeBridge Session on OEBs held in November 2023.

This webinar will explain what Occupational Exposure Limits (OELs) are and how, when, and by whom they are established. It will also explain the differences between Occupational Exposure Bands (OEBs)/Occupational Health Categories (OHCs) and OELs and the relevance of OEL to support the adequate control of workplace exposure to APIs and the protection of workers.

Speakers:

  • Martin Kohan, Managing Toxicologist at SafeBridge Europe, Ltd.

This webinar will be recorded.

We look forward to seeing you there.

Type
Webinar
Date
9 May 2024 15:00–16:00 London
Language
English
This event is in the past
  • Health & Safety
This resource was published on 3 April
The PSCI publishes Audit Findings Analysis Report

The PSCI publishes Audit Findings Analysis Report

Report

The PSCI shares its first public Audit Findings Report, providing insight and visibility over key risks, trends, and improvements in the pharmaceutical and healthcare supply chain.

As part of the PSCI's goal to promote consistency, quality, and innovation in all aspects of supplier evaluation and audit, we analyze PSCI audits conducted and uploaded on our shared platform on an annual basis. This report shows what we’ve found by analyzing 3,500 findings from 339 PSCI audits conducted during 2020-2022 and uploaded to the PSCI platform by the end of 2022.

We are specifically interested in understanding how the findings are distributed across the five areas of the PSCI Principles, our blueprint for responsible supply chain management & foundation of our tools. This analysis gives us visibility over how findings are changing over time and our impact on the industry.

This report, the first we have shared publicly, shows the results of a deep dive analysis into each area, focusing on 1,955 findings from 195 PSCI audits uploaded by the end of 2022. These findings reveal key risks, areas for improvement, and opportunities for PSCI members to support their suppliers to improve their practices.

This analysis also provides a high-level understanding of regional differences and levels of maturity, allowing us to provide regionally specific support on hot topics through our capability building work and begin to understand our own impact on the industry.

Speaking of the report's publication, Dorota Wiacek-Trojanowska, Audit Committee member says,

The annual analysis of audit results carried out by the PSCI not only provides information enabling the identification of the most important challenges faced by both PSCI members and suppliers, but also shows new challenges that we must be able to face. The audit results give us the opportunity to collect and analyze information on the biggest challenges in ensuring a sustainable supply chain in the whole pharma sector.